Editas Medicine Ownership

Editas Medicine holds a total of 82.55 Million outstanding shares. The majority of Editas Medicine outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Editas Medicine to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Editas Medicine. Please pay attention to any change in the institutional holdings of Editas Medicine as this could imply that something significant has changed or is about to change at the company. On May 1, 2021, Representative Donald S Beyer Jr of US Congress acquired under $15k worth of Editas Medicine's common stock. Some institutional investors establish a significant position in stocks such as Editas Medicine in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Editas Medicine, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits. Dividends Paid is likely to drop to 3,420 in 2024. Dividend Paid And Capex Coverage Ratio is likely to drop to -29.41 in 2024. Common Stock Shares Outstanding is likely to drop to about 49.3 M in 2024. Net Loss is likely to gain to about (188.5 M) in 2024. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Editas Medicine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Editas Stock please use our How to Invest in Editas Medicine guide.